Small Molecule Therapies for Rheumatoid Arthritis Market Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024
Market Research Engine has published a new report titled as “Small Molecule Therapies for Rheumatoid Arthritis Market Size, By Product (Disease Modifying Anti-Rheumatic Drugs, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids), By Region, Market Analysis Report, Forecast 2018-2024.”
The scope of the report includes a detailed study of small molecule therapies for rheumatoid arthritis market with the reasons given for variations in the growth of the industry in certain regions.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, and UCB Pharma. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.
The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.
Increasing ageing population and healthcare expenditure will expand the small molecule therapies for rheumatoid arthritis market size over the forecast time line. Rising investments in drug development program and drug discovery will further support in stimulating industry size. Stringent regulations related to efficacy in clinical development may affect the industry revenue generation till 2024.
Regulatory approvals for leflunomide and etanercept has led to various developments in the disease modifying anti-rheumatic drugs (DMARDs) which are used for the treatment of rheumatoid arthritis. Of which leflunomide is a small molecule and non-biological DMARD, whose usage will support in promoting industry growth rate during the study period.
The small molecule therapies for rheumatoid arthritis market is segmented on the lines of its product and regional. The basis of product the market is segmented into Disease Modifying Anti-Rheumatic Drugs, Non-Steroidal Anti-Inflammatory Drugs, and Corticosteroids. The small molecule therapies for rheumatoid arthritis market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, and UCB Pharma are among the major players in the global small molecule therapies for rheumatoid arthritis market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Small Molecule Therapies for Rheumatoid Arthritis Market has been segmented as below:
Small Molecule Therapies for Rheumatoid Arthritis Market Research, By Product
- Disease Modifying Anti-Rheumatic Drugs
- Non-Steroidal Anti-Inflammatory Drugs
Small Molecule Therapies for Rheumatoid Arthritis Market, By Region
- North America
- Asia Pacific
- Rest of World
The report covers:
- An overview of the global small molecule therapies for rheumatoid arthritis market and related technologies
- Analyses of global market trends, with actual data for 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2024
- Identifications of new market opportunities and targeted promotional plans for small molecule therapies for rheumatoid arthritis market
- Discussion of research and development, and the demand for new products and new applications.
- Comprehensive company profiles of major players in the industry.
Reasons to Buy this Report:
- Obtain the most up to date information available on the small molecule therapies for rheumatoid arthritis market
- Identify growth segments and opportunities in the industry
- Facilitate decision making on the basis of strong historic and forecast for small molecule therapies for rheumatoid arthritis market
- Assess your competitor’s refining portfolio and its evolution
Request Sample Report from here: https://www.marketresearchengine.com/small-molecule-therapies-for-rheumatoid-arthritis-market
Table of Contents:
- Research Methodology
- Executive Summary
- Market Overview
4.2.1. Ageing population
4.2.2. Attrition of new small molecule drugs in RA clinical development
4.3.1. High cost of RA drugs
4.3.2. Approval of the drug by regulatory authorities
4.4.1. Drug discovery and drug development program
4.4.2. Unmet medical need
4.5.1. Need for rheumatologists
4.5.2. Market dominance by TNF-alpha inhibitors
- Small Molecule Therapies for Rheumatoid Arthritis Market, By Product
- Competitive Landscape
- Company Profile
7.1.1. Company Overview
7.1.2. Product/Service Landscape
7.1.3. Financial Overview
7.1.4. Recent Developments
7.2.1. Company Overview
7.2.2. Product/Service Landscape
7.2.3. Financial Overview
7.2.4. Recent Developments
7.3. Johnson & Johnson
7.3.1. Company Overview
7.3.2. Product/Service Landscape
7.3.3. Financial Overview
7.3.4. Recent Developments
7.4.1. Company Overview
7.4.2. Product/Service Landscape
7.4.3. Financial Overview
7.4.4. Recent Developments
7.5.1. Company Overview
7.5.2. Product/Service Landscape
7.5.3. Financial Overview
7.5.4. Recent Developments
7.6. UCB Pharma
7.6.1. Company Overview
7.6.2. Product/Service Landscape
7.6.3. Financial Overview
7.6.4. Recent Developments
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States